Versant Capital Management, Inc - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 300 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$500
-13.0%
240.0%0.00%
Q2 2023$575
-26.3%
24
-51.0%
0.00%
Q4 2022$780
-22.0%
490.0%0.00%
Q3 2022$1,00049
+122.7%
0.00%
Q3 2021$0
-100.0%
22
-83.8%
0.00%
-100.0%
Q2 2021$3,000
+200.0%
136
+338.7%
0.00%
Q4 2020$1,0000.0%31
-16.2%
0.00%
Q3 2020$1,0000.0%370.0%0.00%
Q2 2020$1,0000.0%370.0%0.00%
-100.0%
Q1 2020$1,000370.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Sio Capital Management, LLC 563,200$16,243,0009.48%
Avoro Capital Advisors LLC 1,486,460$42,870,0008.66%
Baker Brothers Advisors 25,819,768$744,642,0007.30%
SECTORAL ASSET MANAGEMENT INC 1,176,543$33,932,0003.76%
HARVEY CAPITAL MANAGEMENT INC 251,825$7,262,0003.38%
ACUTA CAPITAL PARTNERS, LLC 300,000$8,652,0003.22%
Palo Alto Investors LP 1,532,030$44,184,0002.52%
Ghost Tree Capital, LLC 350,000$10,094,0002.43%
EMORY UNIVERSITY 76,121$2,195,0002.16%
WEATHERBIE CAPITAL, LLC 576,784$16,634,0002.09%
View complete list of ACADIA PHARMACEUTICALS INC shareholders